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Supplementary Figure 1.  Full-length agarose gel: reverse transcription-polymerase chain reaction (RT-
PCR) with TAAR9 and HPRT (housekeeping gene) specific primers using RNA isolated from the main 
olfactory epithelium (MOE) of WT, KOdelC, and KOinsA rats confirmed a corresponding decrease in 
TAAR9 mRNA expression in the main olfactory epithelium (MOE) of both KO strains. Negative control 






Supplementary Table 1. Comparative hematological analysis of TAAR9-KO and WT rats.  













WT TAAR9-KOinsA TAAR9-KOdelC 
Basic parameters 
MCV(fL) 55,63 ± 0,72 57,50 ± 0,45 54,06 ± 0,39 
CHCM(g/dL) 32,44 ± 0,27 32,40 ± 0,18 33,03 ± 0,20 
CH(g/dL) 18,01 ± 0,27 18,61 ± 0,13 17,88 ± 0,19 
HDW(g/dL) 2,78 ± 0,39 2,98 ± 0,04 3,14 ± 0,03 
PLT(10*3/μl) 524,75 ± 80,36 445,13 ± 40,66 459,38 ± 56,83 
MPV(fL) 9,26 ± 0,49 9,49 ± 0,53 9,39 ± 0,32 
WBC differential 
LUC 0,26 ± 0,07 0,36 ± 0,08 0,20 ± 0,06 
LI 2,34 ± 0,02 2,35 ± 0,04 2,35 ± 0,04 
MPXI 30,53 ± 6,58 40,18 ± 5,64 20,48 ± 5,99 
WBCP(10*3/μl) 8,46 ± 0,85 11,48 ± 1,32 8,95 ± 1,57 
Reticulocytes 
Retic(%) 2,14 ± 0,09 2,07 ± 0,16 1,92 ± 0,13 
CHr(pg) 23,64 ± 0,35 24,25 ± 0,08 22,95 ± 0,26 
CHm(pg) 23,99 ± 2,04 26,75 ± 2,49 25,99 ± 2,76 
Additional 
parameters 
%Hyper 3,30 ± 0,54 2,30 ± 0,38 3,43 ± 0,32 




0,05 ± 0,00 0,04 ± 0,00 0,04 ± 0,01 
RBC 
Ghosts(10*6/μl) 
0,02 ± 0,00 0,02 ± 0,00 0,02 ± 0,00 
Neut X 21,11 ± 0,14 21,42 ± 0,42 21,62 ± 0,32 
Neut Y 27,86 ± 0,16 27,67 ± 0,17 27,84 ± 0,19 
MNx 16,00 ± 0,29 15,58 ± 0,27 16,50 ± 0,45 
MNy 11,71 ± 0,96 12,50 ± 0,00 10,17 ± 1,33 
%MN 73,97 ± 8,33 75,18 ± 5,40 73,47 ± 8,51 
%PMN 25,63 ± 8,36 24,45 ± 5,42 25,97 ± 8,59 
Cellular 
HGB(g/dL) 
14,84 ± 0,50 14,35 ± 0,65 14,63 ± 0,52 
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Supplementary Table 2. Comparative blood biochemical analysis of TAAR9-KO and WT rats. 




Parameters (units) WT TAAR9-KOinsA TAAR9-KOdelC 
Lipase (IU/L) 11.76 ± 0,92  7.89 ± 1,24  13.52 ± 3,19  
Lactate dehydrogenase (U/L) 399.29 ± 46,07  255.00 ± 15,48  367.33 ± 47,10  
Total protein (g/L) 63.51 ± 2,48  53.47 ± 3,21  60.27 ± 2,20  
Phosphorus (mmol/L) 2.57 ± 0,13  2.21 ± 0,22  2.26 ± 0,08  
Glucose (mmol/L) 7.73 ± 0,44  7.30 ± 0,42  7.72 ± 0,48  
Creatinine (umol/L) 70.56 ± 17,06  44.76 ± 3,38  69.67 ± 10,73  
Total bilirubin (umol/L) 1.65 ± 0,18  1.53 ± 0,24  1.33 ± 0,12  
Albumin (g/L) 28.51 ± 0,87  25.51 ± 1,27  27.50 ± 0,77  
Urea (mmol/L) 8.87 ± 1,27  6.00 ± 0,22  10.00 ± 1,13  
5 
 
Supplementary Meta-analysis 1. TAAR9 expression in organs involved in cholesterol metabolism 
regulation (RNAseq datasets meta-analysis). 
 
Cholesterol concentration in plasma depends on exogenous and endogenous sources under 
complex regulation. Approximately half of the dietary cholesterol entering the intestines is absorbed [1]. 
The liver plays the main role in cholesterol metabolism. In this organ, cholesterol contributes to de novo 
synthesis and storage. High-density lipoprotein formation, cholesterol-containing chylomicron remnants 
and low-density lipoprotein particles uptake from plasma also occur in the liver [2]. Cholesterol up taking 
in hepatocytes is also insulin-dependent [3].  The inverse association between insulin and LDL 
cholesterol plasma levels is described both in normoglycemic and diabetic subjects [4]. The liver is also 
the principal site of cholesterol excretion, converting cholesterol to bile acids and removing free 
cholesterol as neutral sterols via biliary excretion [5]. Circulating levels of leptin showed a significant 
positive correlation with LDL-cholesterol and a negative correlation with HDL-cholesterol [6], so the 
cholesterol metabolism depends also on adipokines from adipose tissue. To estimate possible TAAR9 
contribution in cholesterol metabolism regulation, its expression was evaluated in public transcriptomic 
data for intestine, liver, pancreatic islets, and adipose tissue. 
Data collection and inclusion criteria for datasets 
Publically available transcriptome RNAseq datasets were retrieved from GEO (Gene Expression 
Omnibus [9]) repository. First, the GEO browser available on https://www.ncbi.nlm.nih.gov/geo/browse/ 
was searched for the terms “intestine”, “duodenum”, “jejunum”, “ileum”, “liver”, “Langerhans islets”, 
“pancreatic islets”, “fat” or “adipose tissue”.  Datasets were filtered by species “Homo sapiens” or 
“Rattus norvegicus”. Datasets inclusion criteria were as follows: at least 3 samples from healthy adult 
subjects or animals, the mean number of gene reads per sample at least 35 M (if SRA data available), and 
a file with the raw or normalized data attached. 
Taar9 expression data also were searched in Expression Atlas [10] database (available at 
https://www.ebi.ac.uk/gxa/home), and Tabula Muris (available at https://tabula-muris.ds.czbiohub.org, 
[11]). 
RNAseq data processing 
After exclusion of all non-relevant datasets, 19 RNAseq datasets were selected for future analysis. 
GSE IDs and titles data for selected microarray-generated and NGS-generated datasets are listed in 
Supplementary Table S3. Count or normalized count matrices for these datasets were downloaded from 
its supplementary data on GEO Accession Display. Data were TMM normalized and CPM transformed 
by the Bioconductor R package edgeR [2] if necessary. TAAR9 or Taar9 expression data were extracted 
from TMM normalized CPM data for human or rat datasets, respectively. 
Results 
The following human datasets met the inclusion criteria: intestine — 1 dataset, liver — 3, 
Langerhans islets — 2, and adipose tissue — 6. Additionally, included rat datasets were as follows: liver 
— 5 and adipose tissue — 2. Only tissue samples from healthy human or non-treated animals were 
reviewed. No TAAR9 expression was detected in intestinal and liver samples. TAAR9 expression wasn’t 
detected in rat adipose tissue samples, but it was positive in 15 of 520 (3%) human adipose tissue 
specimens. In human pancreatic islets, TAAR9 expression was detected in 99% of specimens; only one 
sample in GSE165121 [10] dataset was TAAR9 expression negative. 
Using the Expression Atlas thresholds [11] as a guide, the TMM normalized CPM values were 
below the cutoff in all adipose tissue specimens in analyzed datasets (i.e. CPM < 0.05). In all islet 
samples in GSE108072 and one sample in GSE165121 [10] datasets was expressed below Expression 
Atlas cutoff. So 28 islet specimens in GSE165121 [10] were TAAR9 expression positive at low levels 
according to Expression Atlas thresholds (i.e. between 0.5 to 10 CPM). 
TAAR9 expression wasn’t detected in the human gastrointestinal tract, liver, pancreas, or adipose tissue 
in the Expression Atlas database [11]. In mice, the low expression below cutoff was detected in the liver 
only [11]. 
Using scRNA-seq data generated by the Tabula Muris we found expression of TAAR9 in mouse 
epithelial cells of the large intestine. Interestingly, most of the cells do not express TAAR9. Only 17 of 
2019 cells (0.84%) are positive for TAAR9 expression. The median expression level 4.2 CPM in this cell 
group may be considered as low positive according to Expression Atlas thresholds (i.e. between 0.5 to 10 
CPM). 
Taking into account low TAARs expression in tissues and heterogeneous distribution of TAAR9 
mRNA between the cells demonstrated in the Tabula Muris dataset, rare TAAR9-positive cases and its 
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Supplementary Table 3. RNAseq datasets included into meta-analysis 
GEO ID Authors Title Structure 
Samples from healthy 




Zorro M et al, 
2021 
RNA sequencing derived from intestinal biopsies from healthy controls and 
celiac disease patients 
Intestine 5 Human 
GSE130970 
Hoang SA et al, 
2019 
Gene expression predicts histological severity and reveals distinct molecular 
profiles of nonalcoholic fatty liver disease 
Liver 6 Human 
GSE126848 
Suppli MP et al, 
2019 
Hepatic transcriptome signatures in patients with varying degrees of non-
alcoholic fatty liver disease compared to healthy normal-weight individuals 
Liver 14 Human 
GSE113024 He X et al, 2018 
Next Generation Sequencing Facilitates Quantitative Analysis of conventional 
and ischemia-free liver transplantation Transcriptomes 
Liver 12 Human 
GSE124819 
Chariker JH et al, 
2019 
Activity-induced changes in the liver transcriptome after chronic spinal cord 
injury 
Liver 37 Rat 
GSE120804 
Huang X et al, 
2019 
Molecular Characterization of a Precision-Cut Rat Liver Slice Model for the 
Evaluation of Anti-Fibrotic Compounds 
Liver 19 Rat 
GSE123987 
Vinnakota KC et 
al, 2019 
Network Modeling of Liver Metabolism to Predict Plasma Metabolite Changes 
During Short-Term Fasting in the Laboratory Rat: Liver Transcriptome 
Changes in Study 3 
Liver 16 Rat 
GSE139098 
Johnson KJ et al, 
2020 
Transcriptional Profiling of Adult Male Rat Liver and Testis following 14 Day 
Myclobutanil Exposure 
Liver 6 Rat 
GSE138454 
Osuru HP et al, 
2020 
Impact of inflammation on hepatic subcellular energetics in anesthetized rats Liver 8 Rat 
GSE165121 
Serion P et al, 
2021 












Boissier R et al 
2020 





Stenvers DJ et al 
2019 
The diurnal rhythm of adipose tissue gene expression is reduced in obese 








GSE156044 Ha CW et al, 2020 
Transcriptomics analysis of mesenteric adipose tissue from Crohn's disease 





Cifarelli V et al, 
2020 
Decreased adipose tissue oxygenation is associated with insulin resistance in 






Moustafa JS et 10, 
2020 





Kumar R et all, 
2020 
RNAseq of perivascular adipose tissue from mesenteric arteries from 





Wang J et all, 
2020 
Transcriptomic analysis of mRNA of inguinal white adipose tissues from ZSF1 
lean and obese rats, ZSF1 obese rats under calorie restriction, as well as ZSF1 
obese rats dosed with Cmpd1. 
Adipose 
tissue 
15 Rat 
 
